Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.37%
)
US TECH 100
28,612.40
(
0.11%
)
Dow Jones
50,579.70
(
0.58%
)
Brent Oil
101.17
(
0.00%
)
Bitcoin
77,359.24
(
0.45%
)
News Focus
News Focus

Replies to post #528 on Akari Therapeutics PLC (AKTX)

Replies to #528 on Akari Therapeutics PLC (AKTX)
icon url

mick

08/05/20 10:39 AM

#534 RE: Ablivious #528

$AKTX Akari Therapeutics PLC (NASDAQ: AKTX): interim update on the Part B placebo-controlled efficacy arm of the study of nomacopan eye drops in atopic keratoconjunctivitis